Ambev Balance Sheet Health
Financial Health criteria checks 6/6
Ambev has a total shareholder equity of R$98.9B and total debt of R$486.4M, which brings its debt-to-equity ratio to 0.5%. Its total assets and total liabilities are R$147.3B and R$48.4B respectively. Ambev's EBIT is R$19.7B making its interest coverage ratio -42.9. It has cash and short-term investments of R$20.9B.
Key information
0.5%
Debt to equity ratio
R$486.41m
Debt
| Interest coverage ratio | -42.9x |
| Cash | R$20.94b |
| Equity | R$98.88b |
| Total liabilities | R$48.40b |
| Total assets | R$147.29b |
Recent financial health updates
Ambev (BVMF:ABEV3) Seems To Use Debt Rather Sparingly
Dec 07
Ambev (BVMF:ABEV3) Could Easily Take On More Debt
Aug 21Is Ambev (BVMF:ABEV3) Using Too Much Debt?
Apr 26Is Ambev (BVMF:ABEV3) A Risky Investment?
Jan 04Recent updates
Ambev (BVMF:ABEV3) Seems To Use Debt Rather Sparingly
Dec 07Ambev S.A.'s (BVMF:ABEV3) Share Price Not Quite Adding Up
Sep 27Ambev (BVMF:ABEV3) Could Easily Take On More Debt
Aug 21Ambev S.A. Just Missed EPS By 9.8%: Here's What Analysts Think Will Happen Next
Aug 03Returns On Capital At Ambev (BVMF:ABEV3) Have Hit The Brakes
May 31Results: Ambev S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates
May 11Is Ambev (BVMF:ABEV3) Using Too Much Debt?
Apr 26Ambev S.A.'s (BVMF:ABEV3) Business Is Yet to Catch Up With Its Share Price
Feb 27There Are Reasons To Feel Uneasy About Ambev's (BVMF:ABEV3) Returns On Capital
Feb 09Is Ambev (BVMF:ABEV3) A Risky Investment?
Jan 04Financial Position Analysis
Short Term Liabilities: ABEV3's short term assets (R$42.7B) exceed its short term liabilities (R$35.7B).
Long Term Liabilities: ABEV3's short term assets (R$42.7B) exceed its long term liabilities (R$12.7B).
Debt to Equity History and Analysis
Debt Level: ABEV3 has more cash than its total debt.
Reducing Debt: ABEV3's debt to equity ratio has reduced from 3.3% to 0.5% over the past 5 years.
Debt Coverage: ABEV3's debt is well covered by operating cash flow (5372.7%).
Interest Coverage: ABEV3 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 08:04 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Ambev S.A. is covered by 37 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Benjamin Theurer | Barclays |
| Berenice Muñoz | Barclays |